“…The clinical characteristics of the present cohort are shown in Table 1 (median age 70 years, interquartile range 58-81 years; 15 males, 10 females; 7 primary, 18 secondary; 6 HCV, 5 HBV, 14 no liver disease; diffuse large B-cell lymphoma [DLBCL], n = 13, DLBCL + mucosa-associated lymphoid tissue, n = 2, mucosa-associated lymphoid tissue [11] , n = 2, Hodgkin's lymphoma, n = 2, B-cell lymphoma [details unknown], n = 2, DLBCL + methotrexateassociated lymphoproliferative disorders [MTX-LPD], n = 1, T-cell lymphoma + MTX-LPD, n = 1, adult T-cell lymphoma, n = 1, MTX-LPD [12] , n = 1). The median tumor size was 26 mm (interquartile range 17-50 mm).…”